T1	Participants 167 218	Japanese Children's Cancer and Leukemia Study Group
T2	Participants 226 333	1981 to 1983, 131 previously untreated patients with acute lymphoblastic leukemia (ALL) standard-risk group
T3	Participants 379 413	119 eligible patients, 115 (96.6%)
